medRxiv
Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease
Preprint: non-randomised trial in peopleAlzheimer's disease
Papers by Gregory Klein
11 results
- Alzheimer's & Dementia
Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal
Trial in peopleInterventions - AAIC 2025 Abstract
External Validation of Joint Propagation Model‐Based Tau PET CenTauR units
Study in peopleBiomarkers
- AAIC 2025 Abstract
TRONTIER 1 and TRONTIER 2: Pivotal trials of trontinemab in early symptomatic Alzheimer’s disease
Trial in peopleInterventions - AAIC 2025 Abstract
External Validation of Joint Propagation Model‐Based Tau PET CenTauR units
Study in peopleBiomarkers - AAIC 2025 Abstract
Impact of non‐linear SUVR transformations on the statistical power of tau‐PET longitudinal studies
Computational studyBiomarkers